Why Hire Us
Compensation may be available, but taking action quickly matters.
Compensation may be available, but taking action quickly matters.



For over 35 years, The Oshman Firm has represented individuals harmed by dangerous drugs, defective products, and corporate negligence.
Many patients prescribed Dupixent believed they were treating severe eczema or chronic inflammation. Later, some were diagnosed with Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Sézary Syndrome, or other serious T-cell malignancies after symptoms continued worsening during treatment.
Our attorneys handle nationwide pharmaceutical litigation involving medications linked to delayed diagnoses and serious health complications. We are committed to helping patients pursue answers, accountability, and compensation when medications allegedly cause devastating harm.
By Ted Oshman Throughout His Career
By The National Trial Lawyers
For More Than a Decade
We understand that many patients contacting our firm are already facing overwhelming medical, financial, and emotional stress.
Consultations with our legal team are:
100% free
Completely confidential
Available nationwide
Offered with no obligation
We also handle Dupixent lawsuits on a contingency fee basis, meaning you pay nothing unless we recover compensation for you.

Ted Oshman has spent more than three decades representing individuals harmed by dangerous drugs, defective medical products, medical negligence, and corporate misconduct.
Throughout his career, Ted has recovered more than $500 million for clients and has played major roles in nationwide pharmaceutical and product liability litigation involving life-changing injuries and catastrophic losses.
Ted understands that Dupixent lawsuits involve far more than medication side effects alone. Many patients now face questions about whether an earlier lymphoma diagnosis could have changed the course of treatment, improved medical outcomes, or prevented years of worsening symptoms.
His work focuses on helping people stand up to major pharmaceutical corporations and pursue accountability when medications allegedly contribute to devastating health complications.
Ted has been recognized as a Super Lawyer for more than a decade and was named among the Top 100 Trial Lawyers in America by The National Trial Lawyers.
When he is not representing clients, Ted spends time with his wife and children and remains actively involved in charitable organizations and mentorship initiatives.


✓ We Fight for Patients Harmed by Dangerous Drugs
Our attorneys represent individuals nationwide in pharmaceutical litigation involving dangerous medications, delayed diagnoses, and serious medical complications. We are prepared to pursue aggressive action against pharmaceutical companies when patients suffer preventable harm.
✓✓ We Understand the Impact of a Lymphoma Diagnosis
A diagnosis involving CTCL, Mycosis Fungoides, or another T-cell malignancy can affect every aspect of your life.
Many patients face:
Ongoing cancer treatment
Painful skin symptoms
Physical discomfort
Emotional distress
Financial pressure
Lost income
Fear about the future
Our legal team understands these cases involve real people whose lives may have been permanently altered.
✓✓✓ No Fee Unless We Win
You should not have to worry about legal fees while already facing serious medical concerns and treatment costs.
The Oshman Firm works on a contingency fee basis. That means:
No upfront attorney’s fees
No hourly billing
No payment unless we recover compensation for you

If you believe Dupixent may be connected to your diagnosis or severe health complications, our attorneys can help investigate what happened and determine whether you may qualify for compensation.
When you work with our firm, we may:
Our goal is to help patients pursue accountability while allowing them to focus on treatment, recovery, and their health.

As additional research, FDA safety monitoring, and patient reports continue emerging, more individuals are exploring whether Dupixent may be connected to:
Cutaneous T-Cell Lymphoma (CTCL)
Mycosis Fungoides
Sézary Syndrome
Delayed lymphoma diagnosis
Worsening skin symptoms
Severe vision injuries
Long-term medical complications
Many lawsuits center on allegations that patients were not adequately warned about potential lymphoma risks associated with Dupixent treatment.
Some patients report spending years attempting to treat what they believed was severe eczema before eventually learning they may have been living with an underlying lymphoma.